{"id":77,"date":"2016-08-23T15:16:59","date_gmt":"2016-08-23T14:16:59","guid":{"rendered":"http:\/\/www.groupactionlawyers.co.uk\/blog\/?p=77"},"modified":"2016-12-21T14:37:40","modified_gmt":"2016-12-21T14:37:40","slug":"class-2-medicines-recall-respontin-nebules","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules","title":{"rendered":"Class 2 medicines recall – Respontin Nebules"},"content":{"rendered":"

Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing.<\/p>\n

The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the drugs that have been reported.<\/p>\n

But we all know how serious such small problems with medicines and medical products can be. Our Group Action Lawyers have been fighting for the rights of medical group cases for years, so know all too well how bad things can get…
\n<\/p>\n

Recalling stock<\/h2>\n

Any remaining stock of the four affected batches should be quarantined and returned to the original supplier. The products are being discontinued so no alternative batches will be available.<\/p>\n

Those that receive the Drug Alert should bring it to the attention of any relevant person. It is the responsibility of NHS regional teams to inform the relevant clinics, general practitioners, and community pharmacies.<\/p>\n

For returns and credit enquires, you should contact your local AAH branch or Alliance Healthcare.<\/p>\n

For any medical enquires you should contact GlaxoSmithKline UK Medical Information Department. Click for more information on the recall!<\/a><\/p>\n

Making a claim<\/h3>\n

At the Group Action Lawyers, we specialise in group actions claims<\/a> and have been dealing with high profile medical group actions like the PIP Breast Implant Scandal<\/a>; Metal-On-Metal Hip Implant problems<\/a>; and the Daybrook Dental Action<\/a>, to name a few.<\/p>\n

If you think you have a claim we urge you to contact us. If we think you have a claim we can get you the compensation that you deserve.<\/p>\n","protected":false},"excerpt":{"rendered":"

Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing. The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the … Continue reading Class 2 medicines recall – Respontin Nebules<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[5],"tags":[],"class_list":["post-77","post","type-post","status-publish","format-standard","hentry","category-medical"],"yoast_head":"\nRespontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Respontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk\" \/>\n<meta property=\"og:description\" content=\"Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing. The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the … Continue reading Class 2 medicines recall – Respontin Nebules\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-23T14:16:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-12-21T14:37:40+00:00\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/Fotolia_90772588_XS.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"headline\":\"Class 2 medicines recall – Respontin Nebules\",\"datePublished\":\"2016-08-23T14:16:59+00:00\",\"dateModified\":\"2016-12-21T14:37:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules\"},\"wordCount\":279,\"commentCount\":0,\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules\",\"name\":\"Respontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"datePublished\":\"2016-08-23T14:16:59+00:00\",\"dateModified\":\"2016-12-21T14:37:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/class-2-medicines-recall-respontin-nebules#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Class 2 medicines recall – Respontin Nebules\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Respontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules","og_locale":"en_GB","og_type":"article","og_title":"Respontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk","og_description":"Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing. The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the … Continue reading Class 2 medicines recall – Respontin Nebules","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules","og_site_name":"Group Action Lawyers","article_published_time":"2016-08-23T14:16:59+00:00","article_modified_time":"2016-12-21T14:37:40+00:00","author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/08\/Fotolia_90772588_XS.jpg","twitter_misc":{"Written by":"Admin","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules"},"author":{"name":"Admin","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"headline":"Class 2 medicines recall – Respontin Nebules","datePublished":"2016-08-23T14:16:59+00:00","dateModified":"2016-12-21T14:37:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules"},"wordCount":279,"commentCount":0,"articleSection":["Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules","name":"Respontin Nebules - Class 2 Medicines Recall - GroupActionLawyers.co.uk","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"datePublished":"2016-08-23T14:16:59+00:00","dateModified":"2016-12-21T14:37:40+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/class-2-medicines-recall-respontin-nebules#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Class 2 medicines recall – Respontin Nebules"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":406,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/chewy-calcium-vitamin-d-tablets-being-recalled-for-impurities","url_meta":{"origin":77,"position":0},"title":"Chewy calcium and vitamin-D tablets are being recalled for impurities","author":"Admin","date":"28th December 2016","format":false,"excerpt":"Teva U.K. Limited - a global pharmaceutical company - has recalled a batch of class 2 medicines due to a possible metal contamination. The pharmaceutical company has recently made a precautionary batch recall for a 'small number' of Evacal D3 chewable tablets. The tablets are a calcium-vitamin D supplement used\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":906,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/duloxetine-depression-chronic-pain-relief-drug-recalled","url_meta":{"origin":77,"position":1},"title":"Depression and chronic pain relief drug, Duloxetine, recalled after failing tests","author":"Admin","date":"25th August 2017","format":false,"excerpt":"The drug Duloxetine, more commonly known as its brand name Cymbalta, is generally used to treat depression, anxiety, and chronic pain. It's an active 'serotonin-norepinephrine reuptake inhibitor', providing pain relief for patients with diabetes or sufferers from chronic or widespread pain. The drug is commonly prescribed to people with arthritis\u2026","rel":"","context":"In "Latest"","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1652,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","url_meta":{"origin":77,"position":2},"title":"Latanoprost Timolol eye drops recall","author":"Author","date":"7th September 2018","format":false,"excerpt":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA). The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an \u2018out of specification result for an unknown impurity\u2019 that was identified during testing.\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"eye claims","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":77,"position":3},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2195,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/medoject-hypodermic-and-blunt-fill-needles","url_meta":{"origin":77,"position":4},"title":"Medoject hypodermic and blunt fill needles","author":"Author","date":"21st December 2021","format":false,"excerpt":"An update has recently been issued by the MHRA (Medicines and Healthcare products Regulatory Agency) warning of the potential dangers of Medoject hypodermic and blunt fill needles produced by the manufacturer. After concerns were raised about certain batches, the manufacturer issued a Field Safety Notice recalling the five batches of\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"injection warning","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/silicone_-injection-warning-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2240,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sterility-problems-and-compensation-actions","url_meta":{"origin":77,"position":5},"title":"Sterility problems and compensation actions","author":"Author","date":"8th February 2022","format":false,"excerpt":"Anyone who has been adversely affected by sterility problems could be entitled to pursue a claim for personal injury compensation on a No Win, No Fee basis. As a firm of specialist Group Action Lawyers, we have represented many victims for issues concerning the sterility of equipment and devices, and\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"anti-depressants prescriptions for children","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/xarelto-side-effects.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/77","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=77"}],"version-history":[{"count":5,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/77\/revisions"}],"predecessor-version":[{"id":377,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/77\/revisions\/377"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=77"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=77"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=77"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}